"Why is COVID-19 so hard to treat? Growing evidence points to unique infectious profile." ScienceDaily. www.sciencedaily.com / releases / 2021 / 05 / 210507121720.htm (accessed May 25, 2025).

At the moment CAD is managed using off-label therapies, including rituximab and corticosteroid drugs, and sutimlimab's potential to improve treatment earned it a breakthrough designation from the FDA.

A look at the 2025 global brands rankings. We cut through the hype to deliver practical, observational advice for entrepreneurs and small business owners seeking to build genuinely valuable brands, ...